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tion of the target lysine at the E2 active site (Wu et al., tially affords the simultaneous presence of two ubiqui-
2003). In accordance with this model, which assumes tylation substrates within the same SCF complex, an
that the E2 remains stably bound to SCF during cataly- arrangement that may have consequences for polyubi-
sis, altering the spacing between target lysine and the quitylation. Alternatively, substrate may be bound only
destruction motif affects the rate of ubiquitylation. How- by one F box protein but transiently released and
ever, other SCF substrates such as the cyclin-depen- switched over to its dimerization partner following each
dent kinase inhibitor Sic1 contain multiple lysines close cycle of ubiquitin chain elongation. It is then possible
to the destruction motif, all of which can be efficiently that this switch serves to reposition the growing polyubi-
ubiquitylated by SCFCdc4 in vitro (Petroski and Deshaies, quitin chain to favor the attachment of the most distal
2003). ubiquitin moiety. Thus, there may yet be more unex-
The present work from the Skowyra laboratory pected movements to be discovered within the SCF
touches on several of these issues. Reconstitution of cradle.
SCFCdc4 activity in vitro initially demonstrated that SCFCdc4
directly bound Cdc34 through its RING subunit. How-
Dieter A. Wolf and Rory Geyerever, kinetic studies by Deffenbaugh et al. now show
Department of Cancer Cell Biologythat a fraction of Cdc34 dissociates from SCFCdc4 during
Harvard School of Public HealthSic1 ubiquitylation (Deffenbaugh et al., 2003). Remark-
Boston, Massachusetts 02115ably, this event is primarily driven by an increase in the
Cdc34 dissociation rate constant due to charging with Selected Reading
ubiquitin. Whereas uncharged Cdc34 seems to readily
associate with SCFCdc4, possibly through a RING-inde- Deffenbaugh, A.E., Scaglione, K.M., Zhang, L., Moore, J.M., Bu-
randa, T., Sklar, L.A., and Skowyra, D. (2003). Cell 114, this issue,pendent low-affinity site, this fraction of Cdc34 seems
611–622.to be catalytically inert. These data suggested that dy-
Guardavaccaro, D., Kudo, Y., Boulaire, J., Barchi, M., Busino, L.,namic release of activated Cdc34 is critical for SCFCdc4-
Donzelli, M., Margottin-Goguet, F., Jackson, P.K., Yamasaki, L., andmediated Sic1 ubiquitylation.
Pagano, M. (2003). Dev. Cell 4, 799–812.There are two essential predictions directly resulting
Orlicky, S., Tang, X., Willems, A., Tyers, M., and Sicheri, F. (2003).from this model, which were experimentally confirmed.
Cell 112, 243–256.(1) Impairing the release of Cdc34 from SCF should also
Petroski, M.D., and Deshaies, R.J. (2003). Mol. Cell 11, 1435–1444.impair SCF function. In fact, the F72VCdc34 point mu-
Seol, J.H., Feldman, R.M., Zachariae, W., Shevchenko, A., Correll,tant, which shows a 100-fold increased affinity for the
C.C., Lyapina, S., Chi, Y., Galova, M., Claypool, J., Sandmeyer, S.,RING domain even in the ubiquitin charged form, is con-
et al. (1999). Genes Dev. 13, 1614–1626.
siderably less active in promoting Sic1 ubiquitylation.
Suzuki, H., Chiba, T., Suzuki, T., Fujita, T., Ikenoue, T., Omata, M.,(2) The bulk of Cdc34 should be dissociated from SCF
Furuichi, K., Shikama, H., and Tanaka, K. (2000). J. Biol. Chem. 275,
in vivo. Consistent with this prediction, Deffenbaugh et 2877–2884.
al. show that in crude cell lysate, more than 99% of Verdecia, M.A., Joazeiro, C.A., Wells, N.J., Ferrer, J.L., Bowman,
Cdc34 is in SCF-free form. Nevertheless, this free form M.E., Hunter, T., and Noel, J.P. (2003). Mol. Cell 11, 249–259.
of Cdc34, which is presumably charged with ubiquitin, Wolf, D.A., McKeon, F., and Jackson, P.K. (1999). Curr. Biol. 9,
can fully support SCFCdc4-mediated Sic1 ubiquitylation 373–376.
in vitro. Wu, G., Xu, G., Schulman, B.A., Jeffrey, P.D., Harper, J.W., and
The new data suggest a “hit-and-run” model for Pavletich, N.P. (2003). Mol. Cell 11, 1445–1456.
Cdc34/SCFCdc4-mediated Sic1 ubiquitylation: ubiquitin- Zheng, N., Schulman, B.A., Song, L., Miller, J.J., Jeffrey, P.D., Wang,
charged Cdc34 is transiently recruited to SCFCdc4 but P., Chu, C., Koepp, D.M., Elledge, S.J., Pagano, M., et al. (2002).
Nature 416, 703–709.then released into the vicinity of the E3 bound substrate.
The ability of Cdc34 to rock the rigid SCF cradle in this
way may provide the spatial flexibility required to target
multiple lysines either on the substrate or on the growing
polyubiquitin chain. Interestingly, Deffenbaugh et al. no-
ticed a certain preference of Cdc34 for a particular lysine Secrets of a Secretase:
in Sic1, especially when Cdc34 is limiting, a finding con- N-Cadherin Proteolysissistent with the effective concentration model proposed
Regulates CBP Functionfor SCF-TRCP (Wu et al., 2003). Ubiquitylation of multiple
substrate lysines as noted with Cdc34 concentrations
10-fold above the KD value could therefore be a side
product of the spatial flexibility afforded by the hit-and-
Presenilin (PS-1) is part of the protease -secretaserun mechanism.
that cleaves the membrane proteins APP and Notch.What remains to be addressed in the future is the
In this issue of Cell, Marambaud et al. report that PS-1possibility that SCF ubiquitin ligases form higher-order
cleaves the cell adhesion molecule N-cadherin, releas-molecular complexes. Several F box adaptors, including
ing a C-terminal fragment that promotes degradation ofCdc4 homologs and -TRCP, have been shown to di-
the transcriptional coactivator CBP. Mutations in PS-1merize, and in some cases, dimerization is necessary
associated with Alzheimer’s disease interfere withfor targeting distinct substrates (Guardavaccaro et al.,
CBP proteolysis, leading to abnormal transcription.2003; Suzuki et al., 2000; Wolf et al., 1999). The regions
that mediate dimerization are absent from all crystal
structures of SCFs. F box protein dimerization poten- Alzheimer’s disease (AD), the most common cause of
Cell
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dementia in the elderly, is characterized by memory whether CBP proteolysis is a normal mode of regulation,
loss and progressive cognitive decline. Since its first and many questions remained unanswered: how do
description in 1907, much has been learned about the cleaved intracellular domains and proteasomal degra-
molecular underpinnings of this devastating disease. dation regulate CBP activity under normal conditions,
For example, proteolysis of a Type I transmembrane and what cellular consequences result from disruption
protein, amyloid precursor protein (APP), generates neu- of these processes? Marambaud et al. (2003) report
rotoxic products, A40 and A42. Made throughout life, exciting progress toward answering these questions.
these peptides accumulate abnormally in AD patients. They find that N-cadherin undergoes PS1/-secretase-
APP is cleaved by several proteases, including a large dependent proteolysis to generate a carboxy-terminal
complex termed “-secretase.” Extensive biochemical intracellular cleavage fragment termed “N-Cad/CTF2.”
investigation has revealed that presenilins, multipass Membrane depolarization of neurons stimulated pro-
transmembrane proteins expressed in the brain, serve duction of this fragment in a manner dependent on acti-
either as active site moieties of -secretase or as tightly vation of the N-methyl-D-aspartate (NMDA)-receptor, a
associated obligate cofactors (Selkoe and Kopan, 2003). calcium channel regulated by the common neurotrans-
Progress in understanding PS/-secretase function has mitter glutamate and associated with some forms of
been facilitated by some unexpected mechanistic simi- learning and memory. Overexpression of N-Cad/CTF2
larities between neurodegeneration and cellular devel- repressed CRE-dependent transactivation, while phar-
opment. macological and genetic manipulations that inhibit PS1/
The Notch receptor is a Type I transmembrane protein -secretase activity did the opposite. To elucidate the
that mediates a variety of short-range cell-cell interac- underlying mechanism, the authors hypothesized that
tions during development. In a most unusual signal N-Cad/CTF2 might negatively regulate a protein re-
transduction mechanism, ligand stimulation of Notch quired for CREB-mediated transcription. They show that
leads to PS/-secretase-dependent intramembrane overexpressed N-Cad/CTF2 redistributes CBP from nu-
proteolysis of the receptor, liberating from the mem- cleus to cytoplasm and promotes its proteasomal degra-
brane its intracellular domain (Notch intracellular domain dation. Finally, in a preliminary but provocative connec-
[NICD]), which then translocates to the nucleus and directly tion with disease, the authors report that PS1 mutants
regulates gene expression. Surprisingly, PS/-secretase found in FAD fail to generate N-Cad/CTF2 and fail to
mediates the amyloidogenic intramembrane cleavage suppress CRE-dependent transactivation. In the re-
of APP in a manner analogous to its action on Notch. sulting model, PS1 mutation in familial AD (FAD) causes
This analogy was recently extended with the demonstra- a proteolytic loss-of-function but a transcriptional gain-
tion that the cleaved carboxy-terminal APP intracellular of-function.
domain, like NICD, may function in the nucleus (Cao These novel findings raise several important issues.
and Sudhof, 2001). A variety of Type I transmembrane The evidence for NMDA receptor-dependent N-Cad/
proteins, including cell adhesion molecules and a recep- CTF2 production is intriguing and complements recent
tor tyrosine kinase, release intracellular fragments with work showing a physiological role for neuronal activity-
potential signaling functions after PS/-secretase-
dependent proteolysis of APP (Kamenetz et al., 2003).
dependent cleavage (Fortini, 2002). This substrate diver-
Another major discovery is that CBP is normally down-
sity suggests that regulated intramembrane proteolysis
regulated by an extracellular stimulus through proteoly-
might be a general strategy for communicating cell-
sis of a transmembrane protein. It will be important tosurface events to molecules that regulate gene expres-
determine how N-Cad/CTF2 induces the cytoplasmicsion in the nucleus.
shuttling of CBP, whether their binding interaction isOne such transcriptional regulatory molecule is CREB
direct, and how the ubiquitination machinery is re-binding protein (CBP), a coactivator that promotes gene
cruited. Involvement of other nuclear proteins is sug-transcription by linking a wide variety of DNA binding
gested by the authors’ observation that, in addition totranscription factors, such as CREB, with the basal tran-
its effects on CBP, N-Cad/CTF2 somehow inhibits CREBscription machinery and by modifying various proteins,
binding to its cognate DNA elements. Finally, the interac-such as histones, through its intrinsic acetyltransferase
tion of CBP with a multitude of enhancer factors (Good-activity. CBP, which mediates diverse cellular pro-
man and Smolik, 2000) warrants investigation of thecesses, such as growth, differentiation, and survival,
possibility that its proteolysis could have transcriptionalis thought to be regulated through a combination of
effects extending well beyond CREB-dependent com-phosphorylation events and competitive protein-protein
plexes.interactions (Giordano and Avantaggiati, 1999). The first
The report by Marambaud et al. (2003) enriches ourclue that PS/-secretase might regulate CBP function
understanding of the relationship between mutant pro-came from the discovery that proteolysis of CD44, a
teins and transcriptional dysregulation in neurodegener-ubiquitous cell-surface adhesion molecule, liberates an
ative disorders (Dunah et al., 2002). As the precise con-intracellular domain that somehow potentiates CBP-
nections between PS1 mutations and AD have yet to bemediated transactivation (Okamoto et al., 2001). In this
defined, the challenges ahead are to dissect pathwaysissue of Cell, Robakis and coworkers (Marambaud et al.,
by which abnormal patterns of transcription could lead2003) show that another normal function of PS/-secre-
to neuropathology and to exploit the knowledge of thesetase is to generate a carboxy-terminal fragment of a cell-
mechanisms to develop novel therapeutics. Addressingsurface adhesion molecule, N-cadherin, that downregu-
these challenges will provide critical insight into the rolelates CBP function by targeting CBP for proteolysis.
of regulated proteolysis in transcription, cell survival,Previously, CBP proteolysis was reported in Hunting-
ton’s disease (Jiang et al., 2003), but it was unclear and disease.
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